MX160579A - Procedimiento para producir derivados de hidantoina - Google Patents

Procedimiento para producir derivados de hidantoina

Info

Publication number
MX160579A
MX160579A MX8350A MX835085A MX160579A MX 160579 A MX160579 A MX 160579A MX 8350 A MX8350 A MX 8350A MX 835085 A MX835085 A MX 835085A MX 160579 A MX160579 A MX 160579A
Authority
MX
Mexico
Prior art keywords
procedure
hydantoin derivatives
producing
producing hydantoin
derivatives
Prior art date
Application number
MX8350A
Other languages
English (en)
Inventor
Norio Minami
Masayuki Mathukura
Koichiro Ueda
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of MX160579A publication Critical patent/MX160579A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
MX8350A 1984-01-30 1985-01-28 Procedimiento para producir derivados de hidantoina MX160579A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59013442A JPS60158190A (ja) 1984-01-30 1984-01-30 ヒダントイン誘導体およびその製法ならびにそれを含有する医薬

Publications (1)

Publication Number Publication Date
MX160579A true MX160579A (es) 1990-03-27

Family

ID=11833246

Family Applications (1)

Application Number Title Priority Date Filing Date
MX8350A MX160579A (es) 1984-01-30 1985-01-28 Procedimiento para producir derivados de hidantoina

Country Status (23)

Country Link
US (1) US4650798A (es)
JP (1) JPS60158190A (es)
KR (1) KR870001681B1 (es)
AU (1) AU585207B2 (es)
BE (1) BE901591A (es)
CA (1) CA1249271A (es)
CH (1) CH662354A5 (es)
DE (1) DE3503074A1 (es)
DK (1) DK158668C (es)
ES (2) ES8605523A1 (es)
FI (1) FI83873C (es)
FR (1) FR2558835B1 (es)
GB (1) GB2155466B (es)
HU (1) HU194885B (es)
IE (1) IE850136L (es)
IT (1) IT1184144B (es)
MX (1) MX160579A (es)
NL (1) NL8500248A (es)
NZ (1) NZ210979A (es)
PH (1) PH21920A (es)
SE (1) SE462849B (es)
SU (3) SU1468424A3 (es)
ZA (1) ZA85655B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2708507B2 (ja) * 1988-04-07 1998-02-04 株式会社三和化学研究所 (d)‐6‐フルオロ‐2,3‐ジヒドロ‐2’,5’‐ジオキソ‐スピロ[4H‐1‐ベンゾピラン‐4,4’‐イミダゾリジン]‐2‐カルボキサミド誘導体、これらの製法及び用途
JPH0276882A (ja) * 1988-06-20 1990-03-16 Eisai Co Ltd 光学活性ヒダントイン誘導体
US5206240A (en) * 1989-12-08 1993-04-27 Merck & Co., Inc. Nitrogen-containing spirocycles
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament

Also Published As

Publication number Publication date
GB2155466B (en) 1987-10-07
SE462849B (sv) 1990-09-10
BE901591A (fr) 1985-07-29
SE8500387L (sv) 1985-07-31
ES8605523A1 (es) 1986-03-16
SU1468424A3 (ru) 1989-03-23
GB2155466A (en) 1985-09-25
ES8606293A1 (es) 1986-04-16
ES539942A0 (es) 1986-03-16
FR2558835A1 (fr) 1985-08-02
SE8500387D0 (sv) 1985-01-28
HU194885B (en) 1988-03-28
CA1249271A (en) 1989-01-24
US4650798A (en) 1987-03-17
CH662354A5 (fr) 1987-09-30
DK39585A (da) 1985-07-31
NZ210979A (en) 1987-05-29
JPH0441149B2 (es) 1992-07-07
ES548960A0 (es) 1986-04-16
SU1609453A3 (ru) 1990-11-23
FI83873B (fi) 1991-05-31
PH21920A (en) 1988-04-08
FR2558835B1 (fr) 1990-05-18
AU585207B2 (en) 1989-06-15
HUT38646A (en) 1986-06-30
FI850302L (fi) 1985-07-31
IE850136L (en) 1985-07-30
DK158668B (da) 1990-07-02
NL8500248A (nl) 1985-08-16
KR870001681B1 (ko) 1987-09-22
SU1445559A3 (ru) 1988-12-15
IT8519296A0 (it) 1985-01-30
JPS60158190A (ja) 1985-08-19
FI83873C (fi) 1991-09-10
KR850005442A (ko) 1985-08-26
DK158668C (da) 1990-11-26
AU3806285A (en) 1985-08-08
DK39585D0 (da) 1985-01-29
IT1184144B (it) 1987-10-22
DE3503074A1 (de) 1985-08-08
FI850302A0 (fi) 1985-01-23
GB8502308D0 (en) 1985-02-27
ZA85655B (en) 1985-08-28

Similar Documents

Publication Publication Date Title
ES548445A0 (es) Procedimiento para la obtencion de derivados de azolilmetil-ciclopropil-carbinol sustituido
MX159807A (es) Procedimiento para preparar derivados de bencimidazol
ES556927A0 (es) Procedimiento para la produccion de derivados de la 13-betamilbemicina
ES539784A0 (es) Procedimiento para la obtencion de 5-amino-1-fenil-pirazolessustituidos
ES557807A0 (es) Procedimiento para la fabricacion de derivados gangliosidos
ES548798A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4- hidroxivalerilo
ES548922A0 (es) Procedimiento para preparar nuevos derivados de aminotetra- lina
ES540464A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES557428A0 (es) Procedimiento para la fabricacion de derivados nucleosidos
ES556157A0 (es) Procedimiento para la obtencion de derivados de la 13-beta-milbemicina
ES541029A0 (es) Un procedimiento para preparar derivados de hidantoina
MX159654A (es) Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
MX161397A (es) Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona
ES550961A0 (es) Procedimiento para preparar derivados azolilalquilicos
MX160579A (es) Procedimiento para producir derivados de hidantoina
ES543985A0 (es) Procedimiento para preparar derivados de butiramida
ES545599A0 (es) Procedimiento para la obtencion de derivados de ciclohexeno-na
ES541265A0 (es) Procedimiento para la obtencion de derivados de tiocianopi- rimidina
ES549076A0 (es) Procedimiento para preparar derivados de fenilpiperazina
ES557069A0 (es) Procedimiento para preparar derivados de benzazol
ES546557A0 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
ES547487A0 (es) Procedimiento para la obtencion de derivados de la pirazolo-na
ES541140A0 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
ES545451A0 (es) Procedimiento para la fabricacion de derivados de pirrolidi-na
ES546923A0 (es) Procedimiento para la obtencion de derivados de salicilamida